Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025

Reuters

2025/06/03

Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025

Bruker Corporation has announced significant advancements in mass spectrometry technology at the 73rd American Society for Mass Spectrometry (ASMS) Conference. The company unveiled the timsMetabo™ platform, which offers high-sensitivity analysis for small molecules, specifically targeting PFAS and environmental contaminants. Additionally, Bruker introduced the integration of RECIPE's ClinMass® and ClinDART® assay kits with its EVOQ® DART-TQ⁺ system, aimed at improving therapeutic drug monitoring (TDM) and drugs of abuse (DoA) analysis. These innovations are expected to enhance laboratory productivity by enabling high-throughput, chromatography-free workflows. Bruker plans to further develop solutions for forensic toxicology and emerging contaminants, underlining its commitment to addressing real-world analytical challenges.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250603080303) on June 03, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2540708983"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2540708983\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2540708983?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-03 23:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2540708983","market":"us","top_or_hot":-1,"title":"Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Bruker Corporation has announced significant advancements in mass spectrometry technology at the 73rd American Society for Mass Spectrometry (ASMS) Conference. The company unveiled the timsMetabo™ platform, which offers high-sensitivity analysis for small molecules, specifically targeting PFAS and environmental contaminants. Additionally, Bruker introduced the integration of RECIPE's ClinMass® and ClinDART® assay kits with its EVOQ® DART-TQ⁺ system, aimed at improving therapeutic drug monitoring (TDM) and drugs of abuse (DoA) analysis. These innovations are expected to enhance laboratory productivity by enabling high-throughput, chromatography-free workflows. Bruker plans to further develop solutions for forensic toxicology and emerging contaminants, underlining its commitment to addressing real-world analytical challenges.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250603080303) on June 03, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-03 23:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Bruker Corporation has announced significant advancements in mass spectrometry technology at the 73rd American Society for Mass Spectrometry (ASMS) Conference. The company unveiled the timsMetabo™ platform, which offers high-sensitivity analysis for small molecules, specifically targeting PFAS and environmental contaminants. Additionally, Bruker introduced the integration of RECIPE's ClinMass® and ClinDART® assay kits with its EVOQ® DART-TQ⁺ system, aimed at improving therapeutic drug monitoring (TDM) and drugs of abuse (DoA) analysis. These innovations are expected to enhance laboratory productivity by enabling high-throughput, chromatography-free workflows. Bruker plans to further develop solutions for forensic toxicology and emerging contaminants, underlining its commitment to addressing real-world analytical challenges.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250603080303) on June 03, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4121","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL3RQkZQ:1","article_id":"2540708983","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2540708983","pubTimestamp":1748962835,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025. Bruker Corporation has announced significant advancements in mass spectrometry technology at the 73rd American Society for Mass Spectrometry  Conference. The company unveiled the timsMetabo platform, which offers high-sensitivity analysis for small molecules, specifically targeting PFAS and environmental contaminants. Additionally, Bruker introduced the integration of RECIPE's ClinMass and ClinDART assay kits with its EVOQ DART-TQ system, aimed at improving therapeutic drug monitoring  and drugs of abuse  analysis. These innovations are expected to enhance laboratory productivity by enabling high-throughput, chromatography-free workflows. Bruker plans to further develop solutions for forensic toxicology and emerging contaminants, underlining its commitment to addressing real-world analytical challenges.Disclaimer: This news brief was created by Public ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4121":"生命科学工具和服务","LU1815336091.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AUP\" (USD) INC","BRKR":"布鲁克","LU0757428866.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AE\" (USD) ACC"},"translate_title":"布鲁克公司在ASMS 2025上推出用于药物监测和环境分析的质谱学突破性创新","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BRKR":0.9},"content_text":"Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025\n    \n\n        Bruker Corporation has announced significant advancements in mass spectrometry technology at the 73rd American Society for Mass Spectrometry (ASMS) Conference. The company unveiled the timsMetabo™ platform, which offers high-sensitivity analysis for small molecules, specifically targeting PFAS and environmental contaminants. Additionally, Bruker introduced the integration of RECIPE's ClinMass® and ClinDART® assay kits with its EVOQ® DART-TQ⁺ system, aimed at improving therapeutic drug monitoring (TDM) and drugs of abuse (DoA) analysis. These innovations are expected to enhance laboratory productivity by enabling high-throughput, chromatography-free workflows. Bruker plans to further develop solutions for forensic toxicology and emerging contaminants, underlining its commitment to addressing real-world analytical challenges.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250603080303) on June 03, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}